Idexx Laboratories (IDXX) Total Non-Current Liabilities (2009 - 2026)

Idexx Laboratories (IDXX) has reported Total Non-Current Liabilities for 18 consecutive years, with $529.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 15.87% year-over-year to $529.5 million; the TTM figure through Mar 2026 stood at $529.5 million (down 15.87% YoY), while the FY2025 annual figure was $596.6 million, down 5.34% from the prior year.
• Total Non-Current Liabilities came in at $529.5 million for Q1 2026 at Idexx Laboratories, down from $596.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $983.6 million in Q2 2022, with the low at $529.5 million in Q1 2026.
• Average Total Non-Current Liabilities over 5 years is $773.9 million, with a median of $818.8 million recorded in 2023.
• Across the five-year window, Total Non-Current Liabilities dropped 2.17% in 2022 and dropped 23.95% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $902.2 million in 2022, then retreated by 8.69% to $823.8 million in 2023, then retreated by 23.5% to $630.2 million in 2024, then slipped by 5.34% to $596.6 million in 2025, then slipped by 11.23% to $529.5 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $529.5 million, $596.6 million, and $573.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.